Globus Medical Valuation
| GMED Stock | USD 84.91 1.32 1.58% |
At this time, the firm appears to be undervalued. Globus Medical retains a regular Real Value of $95.58 per share. The prevalent price of the firm is $84.91. Our model calculates the value of Globus Medical from evaluating the firm fundamentals such as Return On Equity of 0.0222, return on asset of 0.0473, and Current Valuation of 11.22 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Globus Medical's valuation include:
Price Book 2.797 | Enterprise Value 11.2 B | Enterprise Value Ebitda 26.3703 | Price Sales 4.6647 | Forward PE 24.6914 |
Undervalued
Today
Please note that Globus Medical's price fluctuation is very steady at this time. Calculation of the real value of Globus Medical is based on 3 months time horizon. Increasing Globus Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Globus stock is determined by what a typical buyer is willing to pay for full or partial control of Globus Medical. Since Globus Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Globus Stock. However, Globus Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 84.91 | Real 95.58 | Target 67.25 | Hype 84.91 | Naive 84.11 |
The real value of Globus Stock, also known as its intrinsic value, is the underlying worth of Globus Medical Company, which is reflected in its stock price. It is based on Globus Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Globus Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Globus Medical helps investors to forecast how Globus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Globus Medical more accurately as focusing exclusively on Globus Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Globus Medical's intrinsic value based on its ongoing forecasts of Globus Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Globus Medical's closest peers. If more than one evaluation category is relevant for Globus Medical we suggest using both methods to arrive at a better estimate.
Globus Medical Cash |
|
Globus Valuation Trend
Comparing Globus Medical's enterprise value against its market capitalization is a good way to estimate the value of Globus Medical uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Globus Valuation Data Drivers
Globus Revenue by Product
Globus Medical Total Value Analysis
Globus Medical is currently forecasted to have valuation of 11.22 B with market capitalization of 11.56 B, debt of 520.4 M, and cash on hands of 408.01 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Globus Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.22 B | 11.56 B | 520.4 M | 408.01 M |
Globus Medical Investor Information
About 82.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 29.94. The company has Price/Earnings To Growth (PEG) ratio of 2.24. Globus Medical had not issued any dividends in recent years. Based on the analysis of Globus Medical's profitability, liquidity, and operating efficiency, Globus Medical may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0806 | 0.0849 |
|
| |||||
| Total Cash From Operating Activities | 156.4 M | 243.5 M |
|
| |||||
| Operating Income | 153.7 M | 133.1 M |
|
|
Globus Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Globus Medical has an asset utilization ratio of 30.84 percent. This indicates that the Company is making $0.31 for each dollar of assets. An increasing asset utilization means that Globus Medical is more efficient with each dollar of assets it utilizes for everyday operations.Globus Medical Ownership Allocation
Globus Medical has a total of 113.74 Million outstanding shares. The majority of Globus Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Globus Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Globus Medical. Please pay attention to any change in the institutional holdings of Globus Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Globus Medical Profitability Analysis
The company reported the previous year's revenue of 1.57 B. Net Income was 122.87 M with profit before overhead, payroll, taxes, and interest of 759.12 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Globus Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Globus Medical and how it compares across the competition.
About Globus Medical Valuation
The stock valuation mechanism determines Globus Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Globus Medical. We calculate exposure to Globus Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Globus Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1 B | 533.4 M | |
| Pretax Profit Margin | 0.11 | 0.10 | |
| Operating Profit Margin | 0.08 | 0.08 | |
| Net Profit Margin | 0.08 | 0.07 | |
| Gross Profit Margin | 0.65 | 0.85 |
Globus Medical Quarterly Retained Earnings |
|
Globus Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Globus Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 114.6 M | |
| Quarterly Earnings Growth Y O Y | 42.231 | |
| Forward Price Earnings | 24.6914 |
Globus Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Globus Medical and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Globus we look at many different elements of the entity such as Globus's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Globus Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Globus Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Globus Medical's worth.Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |